Transcriptomics

Dataset Information

0

Targeting EZH2 in MYCN-amplified Neuroblastoma

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE85432 | GEO | 2017/12/02

SECONDARY ACCESSION(S): PRJNA338446

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics AhR promotes dedifferentiation in MYCN amplified neuroblastoma
2023-10-10 | GSE224391 | GEO
Transcriptomics EP300 selectively controls the enhancer landscape of MYCN-amplified neuroblastoma
2021-11-09 | GSE159617 | GEO
Genomics Super-enhancer Driven Core Regulatory Circuitry in MYCN-amplified Neuroblastoma
2018-05-22 | GSE94824 | GEO
Genomics Enhancer invasion shapes MYCN dependent transcriptional amplification in neuroblastoma
2016-09-01 | E-GEOD-80154 | biostudies-arrayexpress
Transcriptomics The SAGA complex maintains the oncogenic gene expression program in MYCN-amplified neuroblastoma
2024-04-19 | GSE211355 | GEO
Transcriptomics Transcriptional changes and H3K27ac occupancy associated with resistance to JQ1 treatment in MYCN-amplified neuroblastoma
2018-12-13 | GSE107708 | GEO
Transcriptomics Pre-clinical spheroid models identify BMX as a therapeutic target for metastatic MYCN non-amplified neuroblastoma
2024-06-30 | GSE223902 | GEO
Transcriptomics Targeting transcription-replication conflicts is an effective therapeutic principle for MYCN-driven neuroblastoma
2020-11-27 | GSE144288 | GEO
Genomics Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
2024-03-02 | GSE240506 | GEO
Transcriptomics Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
2024-03-02 | GSE164456 | GEO